Nason G J, O'Connor E M, MacMahon D, Moss B, Considine S W, Cahill A, O'Rourke C, O'Brien F M
Department of Urology, Cork University Hospital, Wilton, Cork, Ireland.
Department of Urology, University Hospital Waterford, Waterford, Ireland.
Ir J Med Sci. 2018 Feb;187(1):33-37. doi: 10.1007/s11845-017-1626-8. Epub 2017 May 6.
The aim of this study was to compare the performance of preoperative risk nomograms or detecting lymph node invasion in a cohort of men undergoing radical prostatectomy (RP).
A retrospective analysis was performed on all men (n = 145) who underwent RP between 2012 and 2015. Preoperative data was inputted to the Memorial Sloan-Kettering Cancer Centre (MSKCC), Partin 2011 and Briganti nomograms and the University of California San Francisco- Centre of the Prostate Risk Assessment tool (UCSF-CAPRA). The risk of lymph node involvement (LNI) was calculated and compared to final histology.
One hundred three (71%) men underwent a lymph node dissection at RP. Ten (9.7%) demonstrated LNI. The median nodal yield was 15 nodes, with no difference between those with LNI and those without (19.5 vs 14.5, p = 0.22).No patient classified as low risk on the UCSF-CAPRA score had evidence of LNI. In patients with LNI, no patient breached the 2% threshold for lymph node dissection (LND) on the MSKCC nomogram; four patients breached the 5% threshold on the Partin tables while three patients breached the 2.5% threshold for the Briganti nomogram.
Nomograms produce useful information regarding risk of disease; however, they often have not been validated on different populations. Risk predictions need to be considered carefully and treatment decisions were made on a patient specific basis.
本研究的目的是比较术前风险列线图在一组接受根治性前列腺切除术(RP)的男性患者中检测淋巴结侵犯的性能。
对2012年至2015年间接受RP的所有男性患者(n = 145)进行回顾性分析。将术前数据输入纪念斯隆凯特琳癌症中心(MSKCC)、2011年帕廷列线图和布里甘蒂列线图以及加利福尼亚大学旧金山分校前列腺风险评估工具(UCSF-CAPRA)。计算淋巴结受累(LNI)的风险并与最终组织学结果进行比较。
103名(71%)男性在RP时接受了淋巴结清扫。10名(9.7%)显示有LNI。淋巴结切除中位数为15个,有LNI和无LNI的患者之间无差异(19.5对14.5,p = 0.22)。UCSF-CAPRA评分分类为低风险的患者均无LNI证据。在有LNI的患者中,没有患者突破MSKCC列线图上2%的淋巴结清扫(LND)阈值;4名患者突破了帕廷表上5%的阈值,而3名患者突破了布里甘蒂列线图上2.5%的阈值。
列线图可提供有关疾病风险的有用信息;然而,它们通常尚未在不同人群中得到验证。需要仔细考虑风险预测,并根据患者的具体情况做出治疗决策。